Search results

Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients.
www.richmondresearchinstitute.org/news/why-more-caution-is-needed-in-administering-qt-prolonging-drugs-to-type-1-diabetic-patients

Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients. 3rd March 2021. 400,000 people are currently living with type 1 diabetes in the UK, one of the highest rates in the world.

News - Richmond Research Institute
www.richmondresearchinstitute.org/news

Diabetes. RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers.

Projects [2022]
www.richmondresearchinstitute.org/dev/projects-2022

Considering the risk of QTc prolongation in patients with diabetes mellitus. View publication. Effect of hyperglycaemia in combination with moxifloxacin on cardiac repolarization in male and female patients with type I diabetes. View publication.

Research - Richmond Research Institute
www.richmondresearchinstitute.org/research

Current studies. 12.061: Type I diabetes monitoring and QTc interval. Diabetes mellitus (DM) is a common metabolic disorder characterised by high blood glucose. It is caused by a lack of pancreatic beta-cell insulin production in type 1 DM.

Cardiac Health - Richmond Research Institute
www.richmondresearchinstitute.org/research/cardiac-health

Jorg Taubel’s. research examines the effects of cardiac ion channel-blocking drugs on ventricular repolarization delay in healthy individuals and those with diabetes type I and type II. Dr.

Publications - Richmond Research Institute
www.richmondresearchinstitute.org/publications

Considering the risk of QTc prolongation in patients with diabetes mellitus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Dr Jorg Taubel - Institute Director and Scientific Lead
www.richmondresearchinstitute.org/scientific-team/dr-jorg-taubel

Scientific Lead - Cardiac Health, Diabetes. Dr Jorg Taubel is an expert in clinical pharmacology with a special interest in cardiac repolarisation changes related to iatrogenic interference with glucostasis.

Professor Giuseppe Rosano - Scientific Lead – Cardiac Health: Sex
www.richmondresearchinstitute.org/scientific-team/professor-giuseppe-rosano

He is president-elect of the Heart Failure Association (HFA), Chairman of the Education Committee of the HFA and Chairman of the Study Group on Diabetes and Hypertension of the HFA.

Publications [dev]
www.richmondresearchinstitute.org/dev/publications-dev

Considering the risk of QTc prolongation in patients with diabetes mellitus. Cardiac. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

About - Richmond Research Institute
www.richmondresearchinstitute.org/about

Diabetes: Dr Jorg Taubel. Sex: Professor Giuseppe Rosano. Electrocardiography: Dr Boaz Mendzelevski. Hypertension Methodology: Appointment pending. Clinical Trial Design and Methodology. Dr Ulrike Lorch. Hepatology. Professor Kevin Moore.

We work with partners at the following organisations: 

richmond research institute

We have a track record in conducting clinical research.

Publications

We present our scientific findings at meetings.

Videos

Our academic research helps improve lives and strengthens scientific insights.

Research